Literature DB >> 3514123

Proteolytic processing and compartmentalization of the primary translation products of mammalian apolipoprotein mRNAs.

J I Gordon, H F Sims, A W Strauss, A M Scanu, C Edelstein, R E Byrne.   

Abstract

The steps involved in the initial assembly of apolipoproteins and lipids into supramolecular arrays (nascent lipoprotein particles) are largely unknown. Examination of the proteolytic processing and compartmentalization of the primary translation products of apolipoprotein mRNAs represents one approach to deciphering the molecular details of lipoprotein assembly. The structures of the primary translation products of seven mammalian apolipoprotein mRNAs has been determined in the past several years. The organization of apolipoprotein signal peptides is typical of eukaryotic prepeptides, although an unusual degree of sequence conservation is present among the signal segments of apo AI, AIV, and E. For those apolipoprotein sequences studied in detail, SRP-dependent cotranslational translocation and proteolytic processing appears to be highly efficient and results in sequestration of the processed protein within the lumen of the endoplasmic reticulum (ER). However the mechanism by which these lipid-binding proteins avoid arrest during their translocation through the lipid bilayer of the ER membrane remains obscure. The two principal human HDL apolipoproteins undergo novel extracellular post-translational proteolytic processing, which results in removal of nonhomologous propeptides. The proteases responsible for proapo AI and AII processing appear to be different. The processing of these proapolipoproteins provides a potential series of steps for regulating the ordered assembly of HDL constituents.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514123     DOI: 10.3109/10409238609115900

Source DB:  PubMed          Journal:  CRC Crit Rev Biochem        ISSN: 0045-6411


  1 in total

1.  Serum amyloid a truncations in type 2 diabetes mellitus.

Authors:  Hussein N Yassine; Olgica Trenchevska; Huijuan He; Chad R Borges; Dobrin Nedelkov; Wendy Mack; Naoko Kono; Juraj Koska; Peter D Reaven; Randall W Nelson
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.